You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The companies will form a joint venture for Todos' cancer tests with Care GB owning 67 percent and Todos owning 33 percent of the new venture.
The company has also seen uptake of HemoScreen in Europe and Australia since PixCell began selling the portable hematology analyzer in those markets.
Koch Disruptive Technologies, Longliv Ventures, and OurCrowd participated in the round, bringing the firm's total funding to date to more than $124 million.
The company recorded $111,000 in revenues from its recently launched SARS-CoV-2 antibody test, which runs on its MosiaQ blood testing platform.
Intalere member hospitals will receive access to Magnolia's alliance member pricing and clinical performance guarantee for Steripath under the agreement.
The high-throughput PK7400 Automated Microplate System is designed for use in blood donor and plasma centers, as well as large reference laboratories.
Atomo also said it has closed an oversubscribed initial public offering and that it intends to float its shares on the Australian Securities Exchange mid-month.
The device is designed to divert and isolate a small volume of the initial blood collected for culture, which is the portion most likely to contain contaminants.
The device is designed to stabilize RNA and DNA from fingerstick blood at room temperature for up to two weeks so that it can be mailed to a lab for analysis.
The specimen discard technology automatically and passively "sidelines" potential contaminants during the blood culture collection process, Kurin said.